> Transient gene expression (TGE) in HEK293 cells was optimized by Vink et al. by co‐expression of human cell cycle inhibitors p21 CIP '/> Transient gene expression using valproic acid in combination with co‐transfection of SV40 large T antigen and human p21 CIP/p27 KIP
首页> 外文期刊>Biotechnology Progress >Transient gene expression using valproic acid in combination with co‐transfection of SV40 large T antigen and human p21 CIP/p27 KIP
【24h】

Transient gene expression using valproic acid in combination with co‐transfection of SV40 large T antigen and human p21 CIP/p27 KIP

机译:使用丙戊酸的瞬时基因表达与SV40大T抗原和人P21 CIP / P27 kip的共转染

获取原文
获取原文并翻译 | 示例
           

摘要

> Transient gene expression (TGE) in HEK293 cells was optimized by Vink et al. by co‐expression of human cell cycle inhibitors p21 CIP /p27 KIP and Simian virus 40 large T antigen (SVLT). In this study, we investigated the effect of this enhancer protein complex on the TGE experiments in a cell‐cycle arrested condition of HEK293F cells induced by valproic acid. Growth profiles, consumptions of nutrients, formations of waste products, and product titers of recombinant human antibodies (huAb) were monitored during the 7‐day cultivation time. Our results showed that the use of enhancer proteins increased the product yields in a growth arrest condition as well. During the growth phase, no differences were detected regarding viable cell densities (VCDs), viabilities, growth rates, and cell diameters between the TGE experiments with and without enhancer proteins. However, during the declining phase VCD and viability showed slightly higher values at day 6 and 7 in the presence of enhancers. Furthermore, we could not detect any differences in glucose and glutamine metabolism during batch cultivations with co‐expression of enhancer proteins. Taken together, the special complex of enhancer proteins did not contribute to further enhancement of growth arrest and shift in the main cell metabolisms, but resulted in higher cell viability during the decline phase. Our observations suggest that the human cell cycle inhibitors p21 CIP /p27 KIP together with very low amount of SVLT antigen may induce alternative functional activities than growth arrest to further improve the yield of recombinant proteins.
机译: > HEK293细胞中的瞬态基因表达(TGE)由Vink等人进行优化。通过对人细胞周期抑制剂的共同表达P21 cip / p27. kip 和Simian病毒40大T抗原(SVLT)。在这项研究中,我们研究了这种增强子蛋白质复合物对由丙戊酸诱导的HEK293F细胞的细胞周期滞留条件下的TGE实验的影响。在7天的培养时间内监测生长型材,营养消耗,废物的形成,以及重组人抗体(Huab)的产品滴度。我们的研究结果表明,使用增强剂蛋白质的使用也在生长阻滞状况下增加产物产量。在生长阶段,没有检测到具有和不含增强子蛋白的TGE实验之间的活细胞密度(VCDS),活性,生长速率和细胞直径的差异。然而,在阶段下降期间,在增强剂存在下,VCD阶段和活力在第6天和第7天显示出稍高的值。此外,在具有增强剂蛋白的共表达的分批培养过程中,我们无法检测葡萄糖和谷氨酰胺代谢的任何差异。占据了增强剂蛋白的特殊综合体,没有促进进一步提高生长抑制和在主要细胞代谢中转变,但在下降期期间导致细胞活力更高。我们的观察结果表明人细胞周期抑制剂P21 cip / p27. kip 与非常少量的SVLT抗原一起可能诱导替代的功能性,而不是生长停滞,以进一步提高重组蛋白的产率。

著录项

  • 来源
    《Biotechnology Progress》 |2019年第3期|共10页
  • 作者单位

    R&

    D Cell Culture Technology of Centralized and Point of Care SolutionsRoche Diagnostics GmbHPenzberg Germany;

    R&

    D Cell Culture Technology of Centralized and Point of Care SolutionsRoche Diagnostics GmbHPenzberg Germany;

    R&

    D Cell Culture Technology of Centralized and Point of Care SolutionsRoche Diagnostics GmbHPenzberg Germany;

    R&

    D Cell Culture Technology of Centralized and Point of Care SolutionsRoche Diagnostics GmbHPenzberg Germany;

    R&

    D Cell Culture Technology of Centralized and Point of Care SolutionsRoche Diagnostics GmbHPenzberg Germany;

    R&

    D Cell Culture Technology of Centralized and Point of Care SolutionsRoche Diagnostics GmbHPenzberg Germany;

    R&

    D Cell Culture Technology of Centralized and Point of Care SolutionsRoche Diagnostics GmbHPenzberg Germany;

    R&

    D Cell Culture Technology of Centralized and Point of Care SolutionsRoche Diagnostics GmbHPenzberg Germany;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物科学;
  • 关键词

    antibody production; cell cycle inhibitors; HEK293; SV40 large T antigen; transient gene expression;

    机译:抗体生产;细胞周期抑制剂;HEK293;SV40大T抗原;瞬态基因表达;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号